4126 - 4150 of 8399 Results
Title
Year
-
OPENTitle: Lack of evidence for association of UQCRC1 with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 101Issue #:Start Page: 297.e1End Page: 297.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938960Citation Count: 9
- Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset2020RESTRICTEDTitle: Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmosetJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 182Issue #:Start Page: 108386End Page: 108386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108386Citation Count: 14
-
RESTRICTEDTitle: The Emerging Role of the Lysosome in Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2399End Page: 2399Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112399Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2399/pdf?version=1604479812Citation Count: 74
- Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias2020RESTRICTEDTitle: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 951End Page: 962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8Best OA location URL: http://manuscript.elsevier.com/S1474442220303148/pdf/S1474442220303148.pdfCitation Count: 283
- Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical Practice2020RESTRICTEDTitle: Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical PracticeJournal Name: Molecular BiologyPublisher: Pleiades Publishing LtdVol: 54Issue #: 6Start Page: 827End Page: 839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1134/s0026893320060060Citation Count: 1
- Estimation of Orofacial Kinematics in Parkinson’s Disease: Comparison of 2D and 3D Markerless Systems for Motion Tracking2020OPENTitle: Estimation of Orofacial Kinematics in Parkinson’s Disease: Comparison of 2D and 3D Markerless Systems for Motion TrackingJournal Name: 2020 15th IEEE International Conference on Automatic Face and Gesture Recognition (FG 2020)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/fg47880.2020.00112Best OA location URL: https://arxiv.org/pdf/2003.08048Citation Count: 4
-
OPENTitle: Hitting the Bullseye: Are extracellular vesicles on target?Journal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/jev2.12032Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12032Citation Count: 18
- KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation2020OPENTitle: KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3242End Page: 3261Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa304Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3242/36134972/awaa304.pdfCitation Count: 81
-
RESTRICTEDTitle: Pharmaceutical Implications of Sex-Related RNA Divergence in Psychiatric DisordersJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 41Issue #: 11Start Page: 840End Page: 850Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tips.2020.09.003Best OA location URL: http://www.cell.com/article/S0165614720302091/pdfCitation Count: 13
-
RESTRICTEDTitle: Preferential microglial activation associated with pathological alpha synuclein transmissionJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 81Issue #:Start Page: 469End Page: 476Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2020.09.027Citation Count: 12
- <p>Sensory Hypersensitivity Severity and Association with Obsessive-Compulsive Symptoms in Adults with Tic Disorder</p>2020OPENTitle: <p>Sensory Hypersensitivity Severity and Association with Obsessive-Compulsive Symptoms in Adults with Tic Disorder</p>Journal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 16Issue #:Start Page: 2591End Page: 2601Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s274165Best OA location URL: https://www.dovepress.com/getfile.php?fileID=63218Citation Count: 20
- Spatio-Temporal Attention and Magnification for Classification of Parkinson’s Disease from Videos Collected via the Internet2020RESTRICTEDTitle: Spatio-Temporal Attention and Magnification for Classification of Parkinson’s Disease from Videos Collected via the InternetJournal Name: 2020 15th IEEE International Conference on Automatic Face and Gesture Recognition (FG 2020)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/fg47880.2020.00008Citation Count: 6
- The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant2020OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: http://www.prd-journal.com/article/S135380202030818X/pdfCitation Count: 37
-
RESTRICTEDTitle: Time for a New Image of Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 11Start Page: 1345End Page: 1345Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.2412Citation Count: 29
-
RESTRICTEDTitle: Unmet needs in Parkinson disease: Motor and non-motorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S7End Page: S12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802020307380/pdfCitation Count: 60
- Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+T cells, and M1 macrophages2020OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 41
-
OPENTitle: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 100Issue #:Start Page: 119.e7End Page: 119.e13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940813Citation Count: 30
-
OPENTitle: Clinical Diagnostic Accuracy of Early/Advanced Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000001016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382425Citation Count: 27
-
OPENTitle: Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECTJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 5Start Page: 1445End Page: 1459Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-020-05085-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-020-05085-2.pdfCitation Count: 16
-
OPENTitle: Association of mitochondrial genomic background with risk of Multiple System AtrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 200End Page: 204Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.040Best OA location URL: http://manuscript.elsevier.com/S1353802020308415/pdf/S1353802020308415.pdfCitation Count: 6
- Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research2020OPENTitle: Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease ResearchJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2383End Page: 2383Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112383Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2383/pdf?version=1604315178Citation Count: 3
- Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials2020RESTRICTEDTitle: Challenges and opportunities for improving the landscape for Lewy body dementia clinical trialsJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-020-00703-5Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-020-00703-5Citation Count: 34
-
RESTRICTEDTitle: Comparison of Machine learning models for Parkinson’s Disease predictionJournal Name: 2020 11th IEEE Annual Ubiquitous Computing, Electronics & Mobile Communication Conference (UEMCON)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/uemcon51285.2020.9298033Citation Count: 1
-
RESTRICTEDTitle: Genome‐Wide Association Studies of Cognitive and Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 424End Page: 433Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28342Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28342Citation Count: 115
- Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples2020OPENTitle: Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samplesJournal Name: AutophagyPublisher: Informa UK LimitedVol: 17Issue #: 9Start Page: 2613End Page: 2628Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2020.1834712Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2020.1834712?needAccess=trueCitation Count: 51